Med-Dispense, L.P. Sustainability Profile
Med-Dispense, L.P., headquartered in the United States, is a leading provider in the medical dispensing industry, specialising in innovative medication management solutions. Founded in 2001, the company has established a strong presence across various operational regions, focusing on enhancing patient safety and streamlining pharmacy operations. The core offerings of Med-Dispense include advanced automated dispensing systems and medication management software, designed to improve accuracy and efficiency in healthcare settings. What sets Med-Dispense apart is its commitment to integrating cutting-edge technology with user-friendly interfaces, ensuring seamless adoption by healthcare professionals. With a reputation for reliability and excellence, Med-Dispense has achieved significant milestones, including numerous industry awards and recognitions. The company continues to solidify its market position as a trusted partner for healthcare providers, dedicated to optimising medication delivery and enhancing patient care.
DitchCarbon Score
How does Med-Dispense, L.P.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Med-Dispense, L.P.'s score of 68 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Med-Dispense, L.P., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Emerson Electric Co., from which it inherits climate commitments and performance data. Emerson Electric Co. has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments, which are cascaded down to Med-Dispense, L.P. This relationship ensures that Med-Dispense aligns with industry-standard climate strategies aimed at reducing carbon emissions. While specific reduction targets for Med-Dispense are not detailed, the overarching goals from Emerson Electric Co. reflect a commitment to sustainability and emissions reduction. As a current subsidiary of Emerson Electric Co., Med-Dispense is expected to adhere to the climate pledges and initiatives set forth by its parent company, contributing to a broader effort in the industry to mitigate climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 208,952,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 00,000,000 |
| Scope 2 | 761,996,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 000,000,000,000 |
How Carbon Intensive is Med-Dispense, L.P.'s Industry?
How Carbon Intensive is Med-Dispense, L.P.'s Location?
Med-Dispense, L.P.'s Scope 3 Categories Breakdown
Med-Dispense, L.P.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 3% of Scope 3 emissions.
Top Scope 3 Categories
Med-Dispense, L.P.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Med-Dispense, L.P. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
